[1] |
聂宇东, 潘小刚, 王宏, 等. 抗干扰素-γ自身抗体致成人免疫缺陷综合症13例. 中华结核与呼吸杂志, 2023, 46(2): 144-150. doi:10.3760/cma.j.cn112147-20220725-00625.
|
[2] |
Chen LF, Yang CD, Cheng XB. Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection. Front Immunol, 2021,12:788368. doi:10.3389/fimmu.2021.788368.
|
[3] |
Shih HP, Ding JY, Yeh CF, et al. Anti-interferon-γ autoantibody-associated immunodeficiency. Curr Opin Immunol, 2021, 72:206-214. doi:10.1016/j.coi.2021.05.007.
|
[4] |
Hong GH, Ortega-Villa AM, Hunsberger S, et al. Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States. Clin Infect Dis, 2020, 71(1):53-62. doi:10.1093/cid/ciz786.
pmid: 31429907
|
[5] |
Liew WK, Thoon KC, Chong CY, et al. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies. J Clin Immunol, 2019, 39(5):512-518. doi:10.1007/s10875-019-00652-1.
|
[6] |
Yasamut U, Thongkum W, Moonmuang S, et al. Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains. Front Immunol, 2019, 10:1905. doi:10.3389/fimmu.2019.01905.
pmid: 31474987
|
[7] |
Loh KM, Zhong Y, Lin L, et al. When to Test for Anti-Interferon-γ Autoantibody? Clin Infect Dis, 2020, 71(7):e199. doi:10.1093/cid/ciaa129.
pmid: 32052830
|
[8] |
Su HA, Chen HA, Wang SH, et al. Generalized Pustular Eruption in a Patient with Adult-Onset Immunodeficiency Due to Anti-Interferon-Gamma Autoantibodies. Ann Dermatol, 2023, 35(Suppl 2):S350-S351. doi:10.5021/ad.21.111.
|
[9] |
Pattanaprichakul P, Leeyaphan C, Angkasekwinai N, et al. Prevalence and clinical manifestations of cutaneous findings in patients with adult-onset immunodeficiency due to anti-interferon gamma autoantibodies: an eight-year retrospective study. Int J Dermatol, 2023, 62(12):1506-1510. doi:10.1111/ijd.16870.
pmid: 37828737
|
[10] |
Kiratikanon S, Phinyo P, Rujiwetpongstorn R, et al. Adul-tonset immunodeficiency due to anti-interferon-gamma autoantibody-associated Sweet syndrome: A distinctive entity. J Dermatol, 2022, 49(1):133-141. doi:10.1111/1346-8138.16202.
|
[11] |
Su SS, Zhang SN, Ye JR, et al. Disseminated Talaromyces marneffei And Mycobacterium avium Infection Accompanied Sweet’s Syndrome In A Patient With Anti-Interferon-γ Autoantibodies: A Case Report. Infect Drug Resist, 2019, 12:3189-3195. doi:10.2147/IDR.S218836.
|
[12] |
Chan JF, Trendell-Smith NJ, Chan JC, et al. Reactive and infective dermatoses associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: Sweet’s syndrome and beyond. Dermatology, 2013, 226(2):157-166. doi:10.1159/000347112.
|
[13] |
丘敏枝, 叶枫, 钟佳成, 等. 抗γ干扰素自身抗体阳性家系1例. 中华结核和呼吸杂志, 2022, 45(11): 1121-1123. doi:10.3760/cma.j.cn112147-20220322-00225.
|
[14] |
Czaja CA, Merkel PA, Chan ED, et al. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody. Clin Infect Dis, 2014, 58(6):e115-e118. doi:10.1093/cid/cit809.
|
[15] |
Uno S, Uehara E, Kimura T, et al. R-CHOP Chemotherapy for Disseminated Mycobacterium avium Complex Disease due to Anti-Interferon-Gamma Autoantibodies: A Case Report. Open Forum Infect Dis, 2021, 8(6):ofab181. doi:10.1093/ofid/ofab181.
|
[16] |
Laisuan W, Pisitkun P, Ngamjanyaporn P, et al. Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-γ Autoantibodies. Open Forum Infect Dis, 2020, 7(2):ofaa035. doi:10.1093/ofid/ofaa035.
|
[17] |
Chetchotisakd P, Anunnatsiri S. Linezolid in the treatment of disseminated nontuberculous mycobacterial infection in anti-interferon-gamma autoantibody-positive patients. Southeast Asian J Trop Med Public Health, 2014, 45(5):1125-1131.
|
[18] |
谭洁, 詹森林, 邓国防, 等. 抗干扰素γ自身抗体综合征导致哥伦比亚分枝杆菌播散性感染一例. 中华实验和临床感染病杂志(电子版), 2022, 16(3):210-214. doi:10.3877/cma.j.issn.1674-1358.2022.03.011.
|
[19] |
Angkasekwinai N, Suputtamongkol Y, Tantibhedhyangkul W, et al. Efficacy of Bortezomib for Treating Anti-Interferon-Gamma Autoantibody-Associated Adult-Onset Immunodeficiency Syndrome. Clin Infect Dis, 2024, 78(4):1033-1042. doi:10.1093/cid/ciad676.
|
[20] |
中国防痨协会. 耐药结核病化学治疗指南(2019年简版). 中国防痨杂志, 2019, 41(10): 1025-1073. doi:10.3969/j.issn.1000-6621.2019.10.001.
|
[21] |
段鸿飞. 重视耐多药结核病的诊断和治疗. 人口与健康, 2023(3): 92-94.
|
[22] |
Chawansuntati K, Rattanathammethee K, Wipasa J. Minireview: Insights into anti-interferon-γ autoantibodies. Exp Biol Med (Maywood), 2021, 246(7):790-795. doi:10.1177/1535370220981579.
pmid: 33430618
|
[23] |
Kampitak T, Suwanpimolkul G, Browne S, et al. Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature. Infection, 2011, 39(1):65-71. doi:10.1007/s15010-010-0067-3.
pmid: 21128092
|